We are live on ! Find out more
VAM

Visium Asset Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 3.58%
This Fund
S&P 500
This Quarter Est. Return
+13.68%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
10 Year Est. Return
AUM
$6.18B
AUM Growth
+$1.08B
Cap. Flow
+$404M
Cap. Flow %
6.55%
Top 10 Hldgs %
31.51%
Holding
1,163
New
297
Increased
261
Reduced
271
Closed
313

Sector Composition

Rank Sector Weight
1 Healthcare 53.16%
2 Consumer Discretionary 5.06%
3 Energy 4.01%
4 Utilities 3.23%
5 Financials 3.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STML
301
DELISTED
Stemline Therapeutics, Inc.
STML
$3.05M 0.05%
150,000
HBAN icon
302
Huntington Bancshares
HBAN
$34.4B
$3.05M 0.05%
305,659
+162,082
+113% +$1.54M
STSA
303
DELISTED
STERLING FINL CORP (WA) COM NEW
STSA
$3.04M 0.05%
91,184
-176,470
-66% -$5.71M
CSTM icon
304
Constellium
CSTM
$3.76B
$3.03M 0.05%
+103,300
New +$2.7M
T icon
305
AT&T
T
$159B
$3.03M 0.05%
+114,282
New +$2.87M
BDC icon
306
Belden
BDC
$4.85B
$3.02M 0.05%
43,345
+28,797
+198% +$2M
BZH icon
307
Beazer Homes USA
BZH
$877M
$3.01M 0.05%
150,000
-22,422
-13% -$489K
WWAV
308
DELISTED
The WhiteWave Foods Company
WWAV
$3M 0.05%
105,252
-361,586
-77% -$9.56M
ARTC
309
DELISTED
ARTHROCARE CORP
ARTC
$3M 0.05%
62,279
-537,721
-90% -$25.5M
A icon
310
Agilent Technologies
A
$39.1B
$2.99M 0.05%
74,829
+51,433
+220% +$2.12M
CFR icon
311
Cullen/Frost Bankers
CFR
$10.3B
$2.94M 0.05%
37,956
-7,621
-17% -$569K
KGC icon
312
Kinross Gold
KGC
$27.4B
$2.9M 0.05%
+700,000
New +$3.36M
PETX
313
DELISTED
Aratana Therapeutics, Inc.
PETX
$2.88M 0.05%
+155,236
New +$3.11M
QEP
314
DELISTED
QEP RESOURCES, INC.
QEP
$2.88M 0.05%
97,834
+87,916
+886% +$2.64M
UNS
315
DELISTED
UNS ENERGY CORP COM
UNS
$2.88M 0.05%
47,894
-59,580
-55% -$3.57M
GFI icon
316
Gold Fields
GFI
$29B
$2.87M 0.05%
776,746
+437,466
+129% +$1.61M
CSE
317
DELISTED
CAPITALSOURCE INC
CSE
$2.86M 0.05%
196,048
-110,366
-36% -$1.58M
TYC
318
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
$2.85M 0.05%
64,080
-2,054
-3% -$89.7K
KEY icon
319
KeyCorp
KEY
$24.2B
$2.84M 0.05%
199,566
-212,439
-52% -$2.85M
RTX icon
320
RTX Corp
RTX
$290B
$2.83M 0.05%
38,549
-164,212
-81% -$11.8M
FURX
321
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
$2.82M 0.05%
32,404
-280,294
-90% -$21.6M
PRU icon
322
Prudential Financial
PRU
$42.4B
$2.75M 0.04%
32,468
+24,525
+309% +$2.11M
GGG icon
323
Graco
GGG
$12.9B
$2.75M 0.04%
+110,310
New +$2.76M
JPM icon
324
JPMorgan Chase
JPM
$935B
$2.74M 0.04%
45,119
+31,065
+221% +$1.8M
FULT icon
325
Fulton Financial
FULT
$4.66B
$2.67M 0.04%
211,935
+17,001
+9% +$214K

Similar funds

Visium Asset Management's Q1 2014 Portfolio in Review

As of Q1 2014, Visium Asset Management held 1,163 positions worth $6.18B, up 21% from $5.09B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Visium Asset Management deployed $404M of net new capital in Q1 2014, opening 297 new positions and adding to 261 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 286,563 shares worth $86M.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 54% a quarter earlier, followed by Consumer Discretionary and Energy.

On the sell side, the largest reduction was Allergan Inc, an estimated $286M trimmed.

  • Visium Asset Management's largest Q1 2014 buy was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
  • Visium Asset Management added most to Endo International plc in Q1 2014, an estimated $197M increase.
  • Visium Asset Management's biggest Q1 2014 reduction was Allergan Inc, cutting an estimated $286M.
  • Visium Asset Management fully exited Momenta Pharmaceuticals, Inc. in Q1 2014, selling an estimated $64M.
  • Visium Asset Management's ten largest holdings make up 32% of its $6.18B portfolio in Q1 2014.
  • Visium Asset Management opened 297 new positions and closed 313 in Q1 2014.
  • Visium Asset Management's portfolio value rose 21% quarter-over-quarter to $6.18B.

Based on Visium Asset Management's 13F filing for Q1 2014, filed 15 May 2014.